Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 124,150 | 106,101 | 104,854 | 95,321 | 91,500 |
| Marketable Securities | 1,700 | 1,696 | 1,693 | 10,433 | 20,413 |
| Receivables | 70,715 | 56,138 | 53,702 | 46,278 | 31,625 |
| Inventories | 49,724 | 48,048 | 33,085 | 32,907 | 32,212 |
| TOTAL | $270,420 | $228,130 | $218,125 | $204,417 | $190,702 |
| Non-Current Assets | |||||
| PPE Net | 128,450 | 119,387 | 111,219 | 104,280 | 92,964 |
| Intangibles | 29,946 | 30,194 | 30,443 | 20,891 | 19,954 |
| Other Non-Current Assets | 1,527 | 1,478 | 4,207 | 4,769 | 17,485 |
| TOTAL | $159,923 | $151,059 | $145,869 | $129,940 | $130,403 |
| Total Assets | $430,343 | $379,189 | $363,994 | $334,357 | $321,105 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,000 | 4,500 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 9,890 | 6,989 | 6,080 | 9,072 | 10,547 |
| Accrued Expenses | 41,809 | 35,819 | 28,695 | 28,324 | 22,454 |
| TOTAL | $61,387 | $54,636 | $58,435 | $37,709 | $33,286 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 2,500 | 2,500 | N/A | N/A |
| Deferred Revenues | 2,398 | 2,044 | 880 | 41 | 18 |
| Other Non-Current Liabilities | 194,916 | 194,900 | 194,593 | 194,593 | 194,624 |
| TOTAL | $195,196 | $197,755 | $197,520 | $195,092 | $195,194 |
| Total Liabilities | $256,583 | $252,391 | $255,955 | $232,801 | $228,480 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 155,852 | 155,598 | 153,674 | 152,427 | 150,369 |
| Common Shares | 8 | 4 | 4 | 4 | 4 |
| Retained earnings | -711,466 | -731,154 | -733,528 | -729,279 | -716,947 |
| Other shareholders' equity | 4,707 | -1,860 | -1,971 | -1,703 | -1,201 |
| TOTAL | $173,760 | $126,798 | $108,039 | $101,556 | $92,625 |
| Total Liabilities And Equity | $430,343 | $379,189 | $363,994 | $334,357 | $321,105 |